Browse the evidence

The depletion of Verrucomicrobia in obese-T2DM patients is associated with a loss of anti-inflammatory state and improved insulin sensitivity, potentially allowing the growth of pro-inflammatory Proteobacteria.

The study suggests that losing certain beneficial bacteria (like Verrucomicrobia) might contribute to insulin resistance. This highlights the importance of gut health in diabetes management, though it does not prescribe a specific probiotic or treatment.

Increased abundance of gram-negative bacteria (Dialister and Allisonella) in obese-T2DM patients is associated with elevated lipopolysaccharide (LPS) levels, which mediates inflammatory response and contributes to insulin resistance.

This finding links specific gut bacteria to inflammation and insulin resistance via LPS. It suggests that maintaining gut barrier integrity and avoiding unnecessary antibiotics may be important for metabolic health, although no specific intervention is tested here.

Skeletal muscle functions as an endocrine organ by synthesizing and secreting myokines (e.g., IL-6, irisin, BDNF) in response to contraction, which exert beneficial effects on remote organs and systemic metabolism.

View exercise as a hormonal therapy, not just calorie burning. When you contract your muscles, they release signaling molecules (myokines) that improve metabolism, brain health, and inflammation. Consistent movement is required to maintain this endocrine function.

Myostatin acts as a negative regulator of muscle growth, and its inhibition is a therapeutic target for muscle disorders and metabolic diseases.

Myostatin is a hormone that naturally limits how much muscle you can build. While current treatments focus on inhibiting it pharmacologically, natural exercise may modulate these pathways, though the paper highlights pharmacological inhibition as the primary therapeutic avenue for muscle disorders.

Adropin34-76 treatment activates pyruvate dehydrogenase (PDH) and downregulates PDH kinase-4 (PDK-4) in skeletal muscle, promoting glucose oxidation in obese mice.

This study indicates that obesity can lead to reduced activity of pyruvate dehydrogenase (PDH), a key enzyme for glucose oxidation. Adropin treatment was shown to restore PDH activity, promoting glucose oxidation. This suggests that maintaining healthy enzyme activity is crucial for metabolic health, and future therapies may target these pathways.

EGCG stimulates autophagy in vascular endothelial cells via a CaMKK- and AMPK-mediated mechanism, leading to the degradation of lipid droplets and reduced ectopic lipid accumulation.

This research suggests that EGCG, a compound found in green tea, may help reduce fat accumulation in blood vessel cells by triggering a cellular cleanup process called autophagy. While this is a laboratory finding using animal cells, it highlights a potential cardiovascular benefit of green tea consumption.

Caloric restriction (CR) extends lifespan and delays aging-related diseases in mammals by reversing age-associated aberrant DNA methylation patterns and activating SIRT1-mediated histone deacetylation.

Caloric restriction, defined as reducing total calorie intake by 25-60% while ensuring all essential nutrients are consumed, is the most effective known environmental intervention for extending lifespan in animal models. It works by triggering epigenetic changes, specifically reversing age-related DNA methylation errors and activating SIRT1, which improves genomic stability and delays disease onset. While direct long-term human lifespan data is lacking, short-term human studies show CR improves metabolic markers like glucose homeostasis and blood pressure.

Caloric restriction prevents or delays the onset of specific aging-related diseases, including cancer, diabetes, cardiovascular disease, and neurodegenerative disorders, in rodents and nonhuman primates.

For humans, strict caloric restriction has been associated with improved biomarkers for diabetes (glucose homeostasis), cardiovascular health (blood pressure, lipid profiles), and potentially reduced risk of neurodegenerative diseases. While it may not guarantee disease prevention, it significantly lowers risk factors associated with these conditions.

GIP receptor antagonists can promote weight loss in non-human primates and rodents, challenging the view that GIP promotes obesity.

Blocking GIP receptors (antagonism) has been shown to reduce weight gain in animal models, suggesting that endogenous GIP may play a role in promoting obesity. This supports the development of GIP antagonists for weight management.

Higher telomerase activity is independently associated with better health status (defined as absence of chronic diseases and high functional independence) in the elderly, regardless of telomere length.

Focus on maintaining high telomerase activity through a healthy lifestyle, particularly a Mediterranean diet, as this enzyme activity is a strong independent predictor of remaining disease-free and functionally independent in old age.

Intermittent fasting preserves pancreatic beta-cell mass and improves glucose tolerance in obesity-induced diabetes by stimulating the autophagy-lysosome pathway.

Intermittent fasting may help preserve insulin-producing cells in obesity, but only if your cells can properly recycle waste (autophagy). If you have underlying cellular defects, fasting might stress your pancreas instead of helping it.

Intermittent fasting stimulates beta-cell regeneration markers (NEUROG3) in obesity-induced diabetes, but this effect is dependent on an intact autophagy-lysosome pathway.

Fasting may trigger regeneration signals in the pancreas during obesity, but this process is blocked if your cells cannot perform autophagy.

Women with Premenstrual Dysphoric Disorder (PMDD) exhibit more severe sleep disturbances and altered circadian hormone rhythms (specifically melatonin and cortisol) during the luteal phase compared to healthy women, including phase delays in melatonin and reduced melatonin amplitude.

If you have PMDD, your sleep issues are likely tied to a physiological resistance to melatonin and altered hormone rhythms during the week before your period. This is a recognized medical condition, not just 'stress'. Discussing chronotherapeutic treatments or hormone-regulating strategies with a healthcare provider may be more effective than standard sleep hygiene advice alone.

Mitochondrial fusion in specific hypothalamic neurons (NPY/Agrp and POMC) regulates energy balance, where impaired fusion in these neurons can lead to resistance to diet-induced obesity or leptin resistance.

Mitochondrial health in the brain plays a role in how your body regulates hunger and stores fat. Disruptions in mitochondrial fusion in specific brain neurons may contribute to obesity and leptin resistance.

The 4.5-kb allele of the BclI restriction fragment length polymorphism at the glucocorticoid receptor (GRL) gene locus is associated with higher abdominal visceral fat (AVF) area, independent of total body fat mass.

If you have a family history of central obesity, your genetics may predispose you to storing fat viscerally, especially if you are lean. This is not a life sentence, but it means you must be vigilant about maintaining a healthy body fat percentage, as the genetic effect is most pronounced in leaner individuals. Focus on consistent physical activity and metabolic health rather than just scale weight.

Exogenous administration of the peptide Spexin causes significant weight loss in rodents with diet-induced obesity by reducing caloric intake and inhibiting adipocyte uptake of long-chain fatty acids.

This research identifies Spexin, a peptide naturally produced by fat tissue, as a regulator of weight. In obese humans, Spexin levels are significantly lower than in lean individuals. In rodent models, restoring Spexin levels via injection reduced food intake and fat storage. While not yet a human therapy, it suggests that low Spexin may contribute to obesity and that restoring it could be a therapeutic strategy.

Insulin-like Growth Factor-I (IGF-I) administration ameliorates liver fibrosis and NASH by inducing cellular senescence in hepatic stellate cells (HSCs), thereby inactivating them and limiting fibrosis progression.

IGF-I shows promise in animal studies for reversing liver scarring (fibrosis) by putting the scar-forming cells into a state of 'senescence' where they stop working. While not yet a standard human treatment, it represents a potential future therapy for advanced liver disease.

Probiotics can improve gut barrier integrity and reduce metabolic endotoxemia (LPS translocation) in obese models, thereby lowering systemic inflammation.

A healthy gut lining helps prevent inflammation, which is linked to obesity. Probiotics may help strengthen this barrier, but the most effective way to support gut health is through a diet rich in fiber and fermented foods.

Male recreational strength trainers using anabolic-androgenic steroids (AAS) exhibit significantly higher rates of substance dependence disorder, anxiety disorders, and recent cocaine use compared to non-users, despite being primarily motivated by aesthetic and performance goals.

If you are a recreational lifter using steroids, be aware that your risk for anxiety, substance dependence, and cocaine use is significantly higher than non-users. Most users are not pros but regular gym-goers. Disclosing this to your doctor is crucial for managing side effects like high blood pressure or lipid issues, even if you feel safe. The motivation is usually aesthetics, not professional competition.

AAS users engage in extensive polypharmacy (averaging 11.1 agents/year) to mitigate adverse effects such as gynecomastia, testicular atrophy, and sexual dysfunction, using agents like tamoxifen, clomiphene, and PDE5 inhibitors.

If you are using AAS, you are likely also using other drugs to manage side effects like gynecomastia or low testosterone. This polypharmacy increases health risks. Be aware of what you are taking and why. Regular blood work is essential to monitor the impact of these combined substances.

Chronic overnutrition triggers intracellular stress (oxidative, ER, and autophagy defects) in the hypothalamus, which activates proinflammatory pathways (IKKβ/NF-κB and JNK), leading to central neuroendocrine dysregulation and metabolic syndrome.

This research suggests that chronic overeating causes inflammation in the brain's hypothalamus, which disrupts the body's ability to regulate weight and blood sugar. Simply focusing on peripheral fat loss might not address the root cause if the brain's regulatory system remains inflamed. Strategies that reduce central inflammation or improve hypothalamic health may be critical for treating metabolic syndrome.

Activation of Toll-like receptor 4 (TLR4) in the hypothalamus by lipid excess is a key mechanism driving central metabolic inflammation, insulin resistance, and obesity.

Inflammation in the brain's lipid-sensing pathways (like TLR4) may drive insulin resistance and weight gain. Reducing central lipid exposure or inflammation might help restore metabolic balance, suggesting that brain health is as important as peripheral fat loss.

Autophagy defects in the hypothalamus contribute to the development of metabolic syndrome, including obesity and insulin resistance.

Maintaining healthy autophagy in the brain may be important for preventing obesity and insulin resistance. Lifestyle factors that promote autophagy, such as fasting or exercise, might support hypothalamic function and metabolic health.

Nonalcoholic fatty pancreas disease (NAFPD) is strongly associated with obesity and metabolic syndrome, serving as an early marker for ectopic fat deposition and increasing the risk of type 2 diabetes, cardiovascular disease, and acute pancreatitis.

If you have obesity or metabolic syndrome, ask your doctor about pancreatic fat if you undergo abdominal imaging (CT/MRI). It is a strong indicator of your overall metabolic health and risk for diabetes and pancreatitis. Managing weight and insulin resistance is the primary way to reduce pancreatic fat.